The Effect of Melatonin on Increasing the Health Related Quality of Life in Non-Metastatic Breast Cancer Patients: Three-Year Follow up a Clinical Trial

CONCLUSION: Long-term use of 18 mg of melatonin for 3 years in patients with non-metastatic breast cancer can lead to an increase in the patients' quality of life.PMID:38622853 | DOI:10.1177/15347354241237520

Source: Cancer Control - April 16, 2024 Category: Cancer & Oncology Authors: Zahra Keshtpour Amlashi Fatemeh Sheida Robab Anbiaee Leili Tapak Seyed Rohallah Hosseini Hossein Mosaedian Nastaran Barati Source Type: research